Phase 2 N=87 Effects of Vivatlac Baby on Crying Behavior of Colicky Babies
Infantile Colic
Primary: Number of Participants With a Reduction of Days Crying Equal or More Than 50 Percent From Baseline — 6; 39 Participants — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=180 Efficacy of Matricariae Chamomilla L., Melissa Officinalis L. and Tyndallized Lactobacillus Acidophilus (H122) for Infantile Colics
Infantile Colics
Primary: Median Daily Crying Time at the End of the Treatment — 50; 55; 80 minutes
Phase 2 N=90 Effects of Acupuncture in the Treatment of Infant Colic
Infant Colic
Primary: Change in Crying Time Per 24 Hour Period. — 220; 212; 230; 186 minutes crying time pr 24 hour
N/A N=80 Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic
Infantile Colic · Colic, Infantile
Primary: Number of Participants With >=50% Reduction in Mean Weekly Crying Duration — 32; 13; 3; 24 Participants — p=0.0001
Phase 2 N=115 Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic
Infantile Colic
Primary: Absolute Change of the Mean Daily Crying and Fussing Time for Three Consecutive Days While on Treatment Versus Baseline. — 284.57; 273.6; 283.91; 185.8 Minutes
N/A N=30 Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
Colic · Inflammation
Primary: Daily Average Crying and Fussing Duration According to Barr Diary Records — 111; 133 minutes
Phase 4 N=60 Lubiprostone, Colonic Motility and Sensation
Healthy
Primary: Colonic Compliance — 16.60; 16.50 mm Hg
Phase 2 N=268 A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy
Pain · Cancer · Colonic Diseases
Primary: Measurements of Visceral Pain, Using a 100-mm Visual Analog Scale (VAS) — 22.27; 18.93; 23.31; 22.22 mm — p=0.506